Results for:

J&ampJ hunts for dengue fever drugs in tie-up with academia

Analysis - Fate of $23 billion L'Oreal stake points to future of Nestle

Sanofi bets on inhaled insulin with MannKind deal

Sanofi held talks with Abbott, Mylan about mature drugs - document

Big Pharma stands to profit by cleaning out its medicine chests

Euro's slide revives hopes of European corporate profits recovery

U.S. clears AstraZeneca over heart drug trial

Eli Lilly copy of $8 billion Sanofi insulin wins EU green light

Sanofi in deal to transfer Toulouse centre to Evotec

How the wheels came off for Sanofi's CEO

Sanofi shares sink as diabetes sales slow, CEO pressured

Exclusive: Express Scripts presses for more drug savings with coverage list

AstraZeneca heart drug boosted by major clinical trial success

Sanofi names CEO, cites 'capabililty to unite teams'

L'Oreal says has means to buy Nestle's stake

US clears AstraZeneca over heart drug trial

Analysis - Plant-based vaccines challenge big pharma for $3 billion flu...

Sanofi says told U.S. about bribery claims in Africa, Mideast

Novartis employee pleaded guilty in Polish bribery case

Exclusive- India's Lupin, U.S. firms weigh bids for GSK's mature drugs:...

Sanofi to stick to bolt-on deals amid pharma M&ampA buzz

Exclusive: First gene therapy drug sets million-euro price record

Sanofi to name new CEO in coming weeks as euro lifts results

Bristol-Myers to invest in Dutch gene therapy company uniQure

Sanofi's new boss could earn more than Total's, less than Pfizer's

Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs:...

Morgan Stanley calls Valeant 'house of cards' in Allergan pitch

Actavis, Sanofi among bidders for Omega Pharma- Bloomberg

Merck explores $15 billion-plus drug portfolio sale - sources

Senior JPMorgan deal maker Elliott to retire in June

Desmarest quits Sanofi board to focus on Total role

GSK to axe U.S. jobs as part of $1.6 billion cost cuts - sources

Sanofi board to meet Tuesday after sacking CEO - sources

Sanofi under fire in France over new CEO's pay package

L'Oreal could sell Sanofi stake to fund acquisitions: CEO

Eli Lilly says 'deeply concerned' by bribery allegations in China

Drugmakers look to push the boundaries of old age

Sanofi board ousts CEO Viehbacher, Chairman Weinberg takes helm

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

Pfizer may have to pay more cash and top $105 billion to win AstraZeneca

Sanofi draws up candidate shortlist for top job - source

GSK cuts U.S. research and sales jobs as market gets tougher

Bristol, Sanofi and Novartis drugs to shine among 2015 launches

L'Oreal CEO says ready to buy out Nestle stake in 2014: paper

Sanofi bets on inhaled insulin with up to $925 million MannKind deal

Plant-based vaccines challenge big pharma for $3 billion flu market

Drugmaker GSK to invest 130 million pounds in African factories, R&ampD

Shares rise as investors put faith in Fed's message

Merck to take on superbugs with Cubist Pharma buy

Sanofi touts new drugs but diabetes outlook disappoints